NDC 50090-0870

Truvada

Emtricitabine And Tenofovir Disoproxil Fumarate

Truvada is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Emtricitabine; Tenofovir Disoproxil Fumarate.

Product ID50090-0870_450b081f-5e7e-4bcb-831d-09e70e281c34
NDC50090-0870
Product TypeHuman Prescription Drug
Proprietary NameTruvada
Generic NameEmtricitabine And Tenofovir Disoproxil Fumarate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2004-08-02
Marketing CategoryNDA / NDA
Application NumberNDA021752
Labeler NameA-S Medication Solutions
Substance NameEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-0870-0

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-0870-0)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0870-3 [50090087003]

Truvada TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021752
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-01-31

NDC 50090-0870-0 [50090087000]

Truvada TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021752
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-11-30

NDC 50090-0870-2 [50090087002]

Truvada TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021752
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-02-28

Drug Details

Active Ingredients

IngredientStrength
EMTRICITABINE200 mg/1

Pharmacological Class

  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

NDC Crossover Matching brand name "Truvada" or generic name "Emtricitabine And Tenofovir Disoproxil Fumarate"

NDCBrand NameGeneric Name
35356-070Truvadaemtricitabine and tenofovir disoproxil fumarate
50090-0870Truvadaemtricitabine and tenofovir disoproxil fumarate
52959-969Truvadaemtricitabine and tenofovir disoproxil fumarate
53808-0805Truvadaemtricitabine and tenofovir disoproxil fumarate
61919-669TRUVADAemtricitabine and tenofovir disoproxil fumarate
61958-0701Truvadaemtricitabine and tenofovir disoproxil fumarate
68071-2112TruvadaTruvada
69189-0701TruvadaTruvada
70518-0097TruvadaTruvada
61958-0704TruvadaTruvada
61958-0705TruvadaTruvada
61958-0703TruvadaTruvada
63629-7581TruvadaTruvada
67296-1237TruvadaTruvada
0093-7607Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
0093-7704Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
0378-1930Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
0904-7172Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
16714-534Emtricitabine and tenofovir disoproxil fumarateEmtricitabine and tenofovir disoproxil fumarate
31722-560Emtricitabine and tenofovir disoproxil fumarateEmtricitabine and tenofovir disoproxil fumarate
33342-106Emtricitabine and tenofovir disoproxil fumarateEmtricitabine and tenofovir disoproxil fumarate
42291-439Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
42385-913Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
42385-953Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
42543-719Emtricitabine and Tenofovir Disoproxil FumarateEMTRICITABINE and TENOFOVIR Disoproxil Fumarate
50090-5957EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
51407-112Emtricitabine and Tenofovir Disoproxil FumarateEMTRICITABINE and TENOFOVIR Disoproxil Fumarate
60219-2092Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
60219-2093Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
60219-2094Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
60219-2095Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
60505-4202Emtricitabine and Tenofovir Disoproxil Fumarateemtricitabine and tenofovir disoproxil fumarate

Trademark Results [Truvada]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRUVADA
TRUVADA
78239720 2915213 Live/Registered
Gilead Sciences, Inc.
2003-04-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.